These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 9065963)
1. Measuring the efficacy of psychopharmacological treatment of psychomotoric restlessness in dementia: clinical evaluation of tiapride. Gutzmann H; Kühl KP; Kanowski S; Khan-Boluki J Pharmacopsychiatry; 1997 Jan; 30(1):6-11. PubMed ID: 9065963 [TBL] [Abstract][Full Text] [Related]
2. [Value of tiapride for agitation in the elderly. Review of published studies]. Roger M; Gerard D; Leger JM Encephale; 1998; 24(5):462-8. PubMed ID: 9850821 [TBL] [Abstract][Full Text] [Related]
3. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence. Soyka M; Schmidt F; Schmidt P Pharmacopsychiatry; 2006 Jan; 39(1):30-4. PubMed ID: 16453252 [TBL] [Abstract][Full Text] [Related]
5. Clozapine for treatment-resistant agitation in dementia. Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
9. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study. Görtelmeyer R; Erbler H Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054 [TBL] [Abstract][Full Text] [Related]
10. A combination of carbamazepine/tiapride in outpatient alcohol detoxification. Results from an open clinical study. Soyka M; Morhart-Klute V; Horak M Eur Arch Psychiatry Clin Neurosci; 2002 Oct; 252(5):197-200. PubMed ID: 12451459 [TBL] [Abstract][Full Text] [Related]
11. Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Allain H; Dautzenberg PH; Maurer K; Schuck S; Bonhomme D; Gérard D Psychopharmacology (Berl); 2000 Mar; 148(4):361-6. PubMed ID: 10928308 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
13. Tiapride and chlordiazepoxide in acute alcohol withdrawal. A controlled clinical trial. Lepola U; Kokko S; Nuutila J; Gordin A Int J Clin Pharmacol Res; 1984; 4(5):321-6. PubMed ID: 6394514 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831 [TBL] [Abstract][Full Text] [Related]
15. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159 [TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
17. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. Paleacu D; Barak Y; Mirecky I; Mazeh D Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. Suh GH; Greenspan AJ; Choi SK Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257 [TBL] [Abstract][Full Text] [Related]
19. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study. Perényi A; Arató M; Bagdy G; Frecska E; Szücs R J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098 [TBL] [Abstract][Full Text] [Related]
20. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]